Literature DB >> 2582083

Identification of Epstein-Barr virus-induced polypeptides in P3HR-1 cells by protein immunoblot.

T B Sculley, D G Sculley, J H Pope.   

Abstract

The protein immunoblot technique was used to identify Epstein-Barr virus-specific antigens present in sodium butyrate-induced P3HR-1 cells. Using sera from patients with either nasopharyngeal carcinoma or arthritis, 16 polypeptides were detected ranging in molecular weight from 22K to 140K. Each of the anti-EA-, anti-VCA-positive sera were found to contain antibodies to different subsets of the antigens. A 72K protein was identified which was consistent with the nuclear antigen (EBNA), and culturing cells in the presence of disodium phosphonoacetate allowed identification of 140K and 22K antigens as late viral products. Treatment of cells with sodium butyrate revealed that expression of some antigens increased in parallel with the time of incubation of the cells in butyrate while other antigens either appeared early and then decreased in intensity or were only present after a number of days of butyrate treatment. One of the antigens which decreased with the time cells were treated with butyrate was EBNA.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 2582083     DOI: 10.1099/0022-1317-66-5-1113

Source DB:  PubMed          Journal:  J Gen Virol        ISSN: 0022-1317            Impact factor:   3.891


  8 in total

1.  Gene mapping and expression of two immunodominant Epstein-Barr virus capsid proteins.

Authors:  W M van Grunsven; E C van Heerde; H J de Haard; W J Spaan; J M Middeldorp
Journal:  J Virol       Date:  1993-07       Impact factor: 5.103

2.  Induction of Epstein-Barr virus nuclear antigens.

Authors:  D J Moss; T B Sculley; J H Pope
Journal:  J Virol       Date:  1986-06       Impact factor: 5.103

3.  EB virus induction is associated with B-cell maturation.

Authors:  D H Crawford; I Ando
Journal:  Immunology       Date:  1986-11       Impact factor: 7.397

4.  Mutational analysis of Epstein-Barr virus nuclear antigen 1 (EBNA 1).

Authors:  M Polvino-Bodnar; J Kiso; P A Schaffer
Journal:  Nucleic Acids Res       Date:  1988-04-25       Impact factor: 16.971

5.  Mapping of the gene coding for Epstein-Barr virus-determined nuclear antigen EBNA3 and its transient overexpression in a human cell line by using an adenovirus expression vector.

Authors:  I Joab; D T Rowe; M Bodescot; J C Nicolas; P J Farrell; M Perricaudet
Journal:  J Virol       Date:  1987-10       Impact factor: 5.103

6.  Maintenance of growth transformation with Epstein-Barr virus is mediated by secretion of autocrine growth factors in two serum-free B-cell lines.

Authors:  J E Shaw; L A Baglia; K Leung
Journal:  J Virol       Date:  1988-09       Impact factor: 5.103

7.  Specific Epstein-Barr virus serological response in patients with nasopharyngeal carcinoma detected by immunoblotting.

Authors:  R Cevenini; M Donati; A Moroni; U Caliceti; A Rinaldi-Ceroni; M La Placa
Journal:  Eur J Epidemiol       Date:  1988-09       Impact factor: 8.082

8.  Viral proteins associated with the Epstein-Barr virus transactivator, ZEBRA.

Authors:  D A Katz; R P Baumann; R Sun; J L Kolman; N Taylor; G Miller
Journal:  Proc Natl Acad Sci U S A       Date:  1992-01-01       Impact factor: 11.205

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.